Asset Management One Co. Ltd. lifted its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 12.8% during the first quarter, according to its most recent disclosure with the Securities and ...

What's driving the shift to spatially resolved molecular analysis? The global in situ hybridization market, valued at USD ...

Bio-Techne Corporation (NASDAQ:TECH), is not the largest company out there, but it saw a decent share price growth of 14% on the NASDAQGS over the last few months.

Bio-Techne Corp. TECH has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV ...

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.